
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy
Keywords: CAFs; cancer-associated fibroblasts; CIS; carcinoma in situ; CSCs; cancer stem cells; CXCL12; CXC ligand 12; CXCR4; CXC chemokine receptor 4; EMT; epithelial mesenchymal transition; HMGB1; high mobility group box 1; MDSCs; myeloid-derived suppressor cells